Biological therapies for atrial fibrillation

Guy Amit, Hao Qin, J. Kevin Donahue

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations


Atrial fibrillation is a prominent cause of morbidity and mortality in developed countries. Current treatment strategies center on controlling heart rate while allowing fibrillation to persist or targeting fibrillation primarily and attempting to maintain sinus rhythm. Pharmacological therapies are largely successful for rate control, although mild toxicities are common. Rhythm control strategies are often unsuccessful, leaving patients in atrial fibrillation despite attempts to maintain sinus rhythm. This review will discuss novel biological strategies that are currently under development and may eventually have impact on the management of atrial fibrillation.

Original languageEnglish
Pages (from-to)222-227
Number of pages6
JournalJournal of Cardiovascular Pharmacology
Issue number3
StatePublished - 1 Sep 2008
Externally publishedYes


  • Arrhythmia
  • Atrial fibrillation
  • Atrioventricular node
  • Cell therapy
  • Gene therapy
  • Heart

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Biological therapies for atrial fibrillation'. Together they form a unique fingerprint.

Cite this